Medtronic Receives FDA Approval of Integrity Coronary Stent

Delivering another innovation for interventional cardiology, Medtronic, Inc. MDT, announced today the U.S. Food and Drug Administration (FDA) approval of the Integrity Coronary Stent System. The new platform for Medtronic's coronary stents, including the Integrity bare-metal stent, is based on an advance in biomedical engineering called continuous sinusoid technology that enables the exploration of other breakthrough device concepts such as a polymer-free drug-filled stent.